Availability : Out of stock
- Used to reduce the high blood sugar level in adults, adolescents and children aged 1 year and above with diabetes mellitus .
- Contains Insulin aspart ,Solution for injection in pre–filled pen
- The solution is clear, colourless and aqueous.
- Due to the faster onset of action, NovoRapid should generally be given immediately before a meal.
- When necessary NovoRapid can be given soon after a meal.
Only 0 left
Details
Method of administration
NovoRapid is a rapid-acting insulin analogue.
NovoRapid is administered subcutaneously by injection in the abdominal wall, the thigh, the upper arm, the deltoid region or the gluteal region. Injection sites should always be rotated within the same region in order to reduce the risk of lipodystrophy and cutaneous amyloidosis (see sections 4.4 and 4.8). Subcutaneous injection in the abdominal wall ensures a faster absorption than other injection sites. Compared to soluble human insulin the faster onset of action of NovoRapid is maintained regardless of the injection site. The duration of action will vary according to the dose, injection site, blood flow, temperature and level of physical activity.
Due to the faster onset of action, NovoRapid should generally be given immediately before a meal. When necessary NovoRapid can be given soon after a meal.
Delivery and Returns
Estimated between Thu. Jan. 31 and Sat. Feb. 16
Includes international tracking
Payments
Estimated between Thu. Jan. 31 and Sat. Feb. 16
Includes international tracking
